Chimeric antigen receptor specific for interleukin-23 receptor
US11981739B2 · kind B2 · utility
0Cited by
26References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2019 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | Sep 15, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a chimeric antigen receptor (CAR) specific for an IL-23 receptor, and to a nucleic acid encoding the same. The present invention further relates to a T cell expressing said CAR, and to the use thereof for treating an autoimmune and/or inflammatory disease or disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.